Award notice Supplies
Suministro de Medicamentos Epoetinas para varias comunidades autónomas centros del Ingesa
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Servicio Murciano de Salud - Junta de Compras
Espinardo - Place of performance
- Espinardo
- Estimated value
- €4,265,895 excl. VAT
- Amount awarded
- €2,509,350 excl. VAT
- Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 27 July 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Suministro respetuoso con el medio ambiente, de Medicamentos Epoetinas para varias comunidades autónomas centros del ingesa en Ceuta y Melilla y organismos de la Administración General Del Estado
Awarded to
3 lots
- Darbepoetina Alfa
- Epotina Beta
- Epoetina Zeta
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33620000
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Suministro de medicamentos con principio activo Factor VIII de la coagulacion recombinante. Servicio Murciano de Salud - Junta de Compras · 20 July 2026 |
TAKEDA FARMACÉUTICA ESPAÑA, S.A. PFIZER, S.L. SWEDISH ORPHAN BIOVITRUM, S.L. (SOBI) BAYER HISPANIA, S.L. NOVO NORDISK PHARMA, S.A. |
€9,441,858 |
| Acuerdo Marco para el suministro respetuoso con el medio ambiente de medicamentos de uso humano para el tratamiento de la hipertensión pulmonar con destino a los centros del ámbito de la sanidad pública valenciana. Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad · 10 August 2026 |
AUROVITAS SPAIN S.A.U VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA EVER Pharma Therapeutics Spain SL JANSSEN CILAG, SA ACCORD HEALTHCARE, SLU AOP ORPHAN PHARMACEUTICALS IBERIA, S.L. Reddy Pharma Iberia SAU Merck Sharp & Dohmme |
€34,122,530 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 515848-2026.